-
. We also collect a cadre of biomarkers to study disease pathology, including brain imaging (Positron Emission Tomography, Magnetic Resonance Imaging) and fluid-based (cerebrospinal fluid, blood/plasma
-
techniques, applying computational neuroimaging, machine learning and fluid dynamics methodologies to interpret these complex datasets. They will work closely with a dynamic team comprised of neurosurgeons
-
cohorts of neurodegenerative disorders, which include clinical, neuroimaging, and fluid biomarker phenotypes. Characterization of the genetic topography of Alzheimer's disease (AD) provides a unique
-
technologies. Plasmas are represented with MHD models, multi-fluid models, and multi-species kinetic models. The research group develops high-order numerical algorithms for these plasma models and implements
-
have access to multiple datasets with cognitive and clinical assessments and fluid and imaging biomarkers. Our cohorts include the Dominantly Inherited Alzheimer Network (DIAN; our longitudinal study of
-
of neurodegeneration. The WashU School of Medicine is renowned for its research cohorts of neurodegenerative disorders, which include clinical, neuropathology, neuroimaging, and fluid biomarker phenotypes. Recent